Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE CROIX DU SUD : revenue, balance sheet and financial ratios

SELARL PHARMACIE CROIX DU SUD is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in REIMS (51100), this company of category PME shows in 2022 a revenue of 3.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE CROIX DU SUD (SIREN 839311172)
Indicador 2024 2023 2022 2021 2020 2019
Ingresos N/C N/C 3 336 064 € N/C N/C N/C
Resultado neto 210 312 € 200 290 € 255 092 € 377 704 € 256 760 € 267 324 €
EBITDA N/C N/C 362 652 € N/C N/C N/C
Margen neto N/C N/C 7.6% N/C N/C N/C

Ingresos y cuenta de resultados

In 2024, SELARL PHARMACIE CROIX DU SUD generates positive net income of 210 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 267 k€ -> 210 k€.

Resultado neto (2024) ?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios

210 312 €

Chargement du compte de résultat...

Évolution graphique

Mostrar :

Activo

Chargement des données...

Pasivo

Chargement des données...

Ratios de solvencia y endeudamiento

The debt ratio (= Financial debt / Equity x 100) stands at 86%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Ratio de endeudamiento (2024) ?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible
50-100% : Moderado
> 100% : Alto

85.91%

Autonomía financiera (2024) ?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Fórmula
(Fondos propios / Total balance) x 100
Interpretación
> 30% : Buena autonomía
20-30% : Media
< 20% : Faible

50.725%

Ratio de obsolescencia (2024) ?
Ratio de obsolescencia
Definición
Mide el grado de desgaste del inmovilizado material.
Fórmula
Amortización acumulada / Inmovilizado bruto x 100
Interpretación
< 50% : Activos recientes
50-70% : Desgaste normal
> 70% : Activos envejecidos

15.5%

Evolución de indicadores de solvencia
SELARL PHARMACIE CROIX DU SUD

Positionnement sectoriel

Debt ratio
85.91 2024
2022
2023
2024
Q1: 16.45
Méd: 58.41
Q3: 154.59
Average

In 2024, the debt ratio of SELARL PHARMACIE CROIX DU... (85.91) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
50.73% 2024
2022
2023
2024
Q1: 28.92%
Méd: 49.95%
Q3: 69.49%
Good +6 pts durante 3 años

In 2024, the financial autonomy of SELARL PHARMACIE CROIX DU... (50.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
5.36 years 2022
2022
Q1: 1.29 years
Méd: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of SELARL PHARMACIE CROIX DU... (5.36) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Ratios de liquidez

The liquidity ratio (= Current assets / Current liabilities) stands at 526.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Ratio de liquidez (2024) ?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno
1-1.5 : Correcto
< 1 : Risque de liquidité

526.029

Evolución de indicadores de liquidez
SELARL PHARMACIE CROIX DU SUD

Positionnement sectoriel

Liquidity ratio
526.03 2024
2022
2023
2024
Q1: 129.47
Méd: 182.14
Q3: 260.79
Excellent

In 2024, the liquidity ratio of SELARL PHARMACIE CROIX DU... (526.03) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
3.19x 2022
2022
Q1: 0.75x
Méd: 2.51x
Q3: 5.16x
Good

In 2022, the interest coverage of SELARL PHARMACIE CROIX DU... (3.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Necesidad de fondo de rotación (NFR) y plazos de pago

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

NFR de explotación (2024) ?
NFR de explotación
Definición
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Fórmula
Stocks + Créances clients - Dettes fournisseurs
Interpretación
Negativo = tesorería liberada
Positivo = necesidad de financiación

0 €

Crédito clientes (2024) ?
Crédito clientes (días)
Definición
Plazo medio de cobro a clientes.
Fórmula
(Cuentas por cobrar / Ingresos con IVA) x 360
Interpretación
< 45j : Bueno
45-60j : Medio
> 60j : Largo

0 j

Crédito proveedores (2024) ?
Crédito proveedores (días)
Definición
Plazo medio de pago a proveedores.
Fórmula
(Cuentas por pagar / Compras con IVA) x 360
Interpretación
Cuanto más largo sea el plazo, mejor para la tesorería

0 j

Rotación de inventario (2024) ?
Rotación de inventario (días)
Definición
Duración media de almacenamiento de mercancías o materiales.
Fórmula
(Existencias / Coste de compra) x 360
Interpretación
Cuanto menor sea el ratio, más rápida es la rotación

0 j

Evolución del NFR y plazos
SELARL PHARMACIE CROIX DU SUD

Positionnement de SELARL PHARMACIE CROIX DU SUD dans son secteur

Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Estimación de valoración

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE CROIX DU SUD is estimated at 2 936 111 € (range 2 044 661€ - 4 392 590€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2044k€ 2936k€ 4392k€
2 936 111 € Range: 2 044 661€ - 4 392 590€
NAF 5 année 2024

Valuation method used

Net Income Multiple
210 312 € × 14.0x = 2 936 111 €
Range: 2 044 661€ - 4 392 590€

Only this financial indicator is available for this company.

Evolución de la valoración

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE CROIX DU SUD with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE CROIX DU SUD

What is the revenue of SELARL PHARMACIE CROIX DU SUD ?

The revenue of SELARL PHARMACIE CROIX DU SUD in 2022 is 3.3 M€.

Is SELARL PHARMACIE CROIX DU SUD profitable?

Yes, SELARL PHARMACIE CROIX DU SUD generated a net profit of 210 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE CROIX DU SUD ?

The headquarters of SELARL PHARMACIE CROIX DU SUD is located in REIMS (51100), in the department Marne.

Where to find the tax return of SELARL PHARMACIE CROIX DU SUD ?

The tax return of SELARL PHARMACIE CROIX DU SUD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE CROIX DU SUD operate?

SELARL PHARMACIE CROIX DU SUD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.